Overview
Higor Iha practices practicing medicine in Osaka, Japan.
Their clinical expertise encompasses Essential Tremor, Drug Induced Dyskinesia, Neurotoxicity Syndromes, and Movement Disorders.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Higor A. Iha
Is Higor A. Iha a top-rated expert for Essential Tremor?
MediFind is an objective health platform that identifies experts based on real-world data. Higor A. Iha is classified as an Experienced expert for Essential Tremor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Higor A. Iha participate in research or clinical trials?
Yes. Higor A. Iha has published 9 articles and abstracts on conditions like Essential Tremor. You can view a list of Higor A. Iha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Drug Induced DyskinesiaIha isExperienced. Learn about Drug Induced Dyskinesia.
- Essential TremorIha isExperienced. Learn about Essential Tremor.
- Movement DisordersIha isExperienced. Learn about Movement Disorders.
- Neurotoxicity SyndromesIha isExperienced. Learn about Neurotoxicity Syndromes.